Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a t...
Q2 2026
Aug 6, 2026
Q1 2026
May 11, 2026
FY 2025
Mar 4, 2026
Q4 2025
Q3 2025
Nov 10, 2025